FDA Approves Nasal Spray for Depression - Newsweek
1 day ago · The FDA has now expanded its approval to include the standalone use of the nasal spray for adults with treatment-resistant major depressive disorder. A stock photo showing a woman's face in shadow.
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and ...
FDA approves Spravato as first stand-along nasal spray to treat drug …
14 hours ago · In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression. 1 weather alerts 1 closings/delays. Watch Now.
FDA allows standalone use of nasal spray antidepressant Spravato ...
1 day ago · The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for depression.
FDA approves Spravato, first monotherapy nasal spray to treat
2 days ago · The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive ...
FDA Approves First Nasal Spray for Treatment of Anaphylaxis
Today, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life-threatening...
FDA approves Johnson & Johnson’s nasal spray for depression as …
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.
FDA Approves Nasal Spray Influenza Vaccine for Self- or …
Sep 20, 2024 · FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the nose and has been used...
5 Things to Know About neffy, the New Nasal Spray for Anaphylaxis
Oct 8, 2024 · The Food and Drug Administration (FDA) approved neffy in August 2024 for adults and children who weigh at least 66 pounds after giving the product a “Fast Track” designation, which expedites the review of drugs that fill an unmet need for people with serious conditions. Anaphylaxis can affect the whole body, cause such complications as ...
FDA Approves First Nasal Spray for Allergic Reactions - WebMD
Aug 9, 2024 · The FDA announced its approval of the nasal spray, called neffy, on Friday. It's for adults, and for children who weigh at least 66 pounds, who have what are known as type 1 allergic reactions,...
- Some results have been removed